Literature DB >> 8631153

Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours.

A Kalkuhl1, K Kaestner, A Buchmann, M Schwarz.   

Abstract

Preneoplastic and neoplastic lesions in rodent liver show alterations in the expression of various enzymes which can be used for their identification. To address the question whether these enzymatic alterations result from specific changes in the levels of hepatocyte-enriched nuclear factors (HNF), we analysed the mRNA levels of six different HNFs (HNF-1alpha, beta, HNF-3alpha, beta, gamma, and HNF-4) by RNase protection assay in chemically induced liver tumours and corresponding normal liver tissue from mice of three different strains. When compared with the normal liver tissue, HNF-1beta, HNF-3alpha and HNF-3beta showed unchanged expression levels in the various liver tumours, which HNF-1alpha and HNF-4 mRNAs were lowered by 20-30%, and HNF-3gamma mRNA was increased by 50%. There were no significant differences in HNF-expression between tumours harbouring point mutations at codon 61 of the Ha-ras protooncogene and tumours without detectable Ha-ras mutations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631153     DOI: 10.1093/carcin/17.3.609

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice.

Authors:  Jessica A Bonzo; Christina H Ferry; Tsutomu Matsubara; Jung-Hwan Kim; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

Review 2.  FOXA1: a transcription factor with parallel functions in development and cancer.

Authors:  Gina M Bernardo; Ruth A Keri
Journal:  Biosci Rep       Date:  2012-04-01       Impact factor: 3.840

Review 3.  Liver enriched transcription factors and differentiation of hepatocellular carcinoma.

Authors:  Y Hayashi; W Wang; T Ninomiya; H Nagano; K Ohta; H Itoh
Journal:  Mol Pathol       Date:  1999-02

Review 4.  Regulation of hepatocyte identity and quiescence.

Authors:  Carmen Berasain; Matías A Avila
Journal:  Cell Mol Life Sci       Date:  2015-06-19       Impact factor: 9.261

5.  Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents.

Authors:  Chad Walesky; Genea Edwards; Prachi Borude; Sumedha Gunewardena; Maura O'Neil; Byunggil Yoo; Udayan Apte
Journal:  Hepatology       Date:  2013-06       Impact factor: 17.425

6.  Comprehensive search for HNF-1beta-regulated genes in mouse hepatoma cells perturbed by transcription regulatory factor-targeted RNAi.

Authors:  Taku Tanaka; Yasuhiro Tomaru; Yuki Nomura; Hisashi Miura; Masanori Suzuki; Yoshihide Hayashizaki
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

7.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

8.  Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation.

Authors:  Chad Walesky; Sumedha Gunewardena; Ernest F Terwilliger; Genea Edwards; Prachi Borude; Udayan Apte
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-25       Impact factor: 4.052

9.  Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.

Authors:  Dan Li; Xiang Zhao; Yong Xiao; Hong Mei; Jiarui Pu; Xuan Xiang; Wanju Jiao; Huajie Song; Hongxia Qu; Kai Huang; Liduan Zheng; Qiangsong Tong
Journal:  Oncotarget       Date:  2015-06-30

10.  VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.

Authors:  Yao-Hui Gao; Zhao-Xia Wu; Li-Qi Xie; Cai-Xia Li; Yu-Qin Mao; Yan-Tao Duan; Bing Han; San-Feng Han; Yun Yu; Hao-Jie Lu; Peng-Yuan Yang; Tian-Rui Xu; Jing-Lin Xia; Guo-Qiang Chen; Li-Shun Wang
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.